Cargando…
Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation
BACKGROUND: Apoptosis-stimulating of p53 protein 2 (ASPP2) is one of the ASPP family members and it has been reported to be associated with human cancer. However, the role of it in pancreatic cancer is still not clear. METHODS: We analyzed the expression level of ASPP2 in cancer tissue samples with...
Autores principales: | Song, Bin, Bian, Qi, Zhang, Yi-Jie, Shao, Cheng-Hao, Li, Gang, Liu, An-An, Jing, Wei, Liu, Rui, Zhou, Ying-Qi, Jin, Gang, Hu, Xian-Gui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594892/ https://www.ncbi.nlm.nih.gov/pubmed/26438046 http://dx.doi.org/10.1186/s12943-015-0447-5 |
Ejemplares similares
-
Downregulation of ASPP2 improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation
por: Chen, Rui, et al.
Publicado: (2016) -
Ulinastatin Reduces the Resistance of Liver Cancer Cells to Epirubicin by Inhibiting Autophagy
por: Song, Bin, et al.
Publicado: (2015) -
ASPP2 promotes cell apoptosis in cervical cancer through inhibiting autophagy
por: Jiang, Feiyun, et al.
Publicado: (2022) -
Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy
por: Wang, Sheng, et al.
Publicado: (2021) -
ASPP2 Plays a Dual Role in gp120-Induced Autophagy and Apoptosis of Neuroblastoma Cells
por: Liu, Zhiying, et al.
Publicado: (2017)